On the other hand, SLC2A1 expression was higher in metastatic cancers than in primary cancers (58 primary tumor versus 58 metastatic tumor samples, p = 0.299) (Fig 1B, left). This evidence concerns the gene SLC2A1 and metastatic malignant neoplasm.